Frequently Asked Questions

December 2014 FAQs

What evidence supports the efficacy of dalbavancin for the treatment of ABSSSIs?

What treatment options are available for the reversal of novel oral anticoagulants?

What is the evidence for the safety and efficacy of tedizolid for the treatment of ABSSSIs?

November 2014 FAQs

What is the status of biosimilars in the United States?

Preexposure prophylaxis for HIV prevention: What are the new guidelines?

How should acute pain be managed in patients taking Suboxone?

October 2014 FAQs

What is the new evidence behind the effectiveness of β-blocker therapy for outcomes post-myocardial infarction?

What are the findings of the HEAT-PPCI trial?

What is the role of thrombolysis in submassive pulmonary embolism?

September 2014 FAQs

What evidence supports the use of extended or continuous infusions for carbapenem administration?

What evidence describes the effect of inhaled morphine for dyspnea or pain?

What is the new guidance regarding palivizumab (Synagis®) administration for respiratory syncytial virus?

August 2014 FAQs

What are the proposals of the new USP <800> chapter, ' Hazardous Drugs – Handling in Healthcare Settings ? '

How should beyond-use-dates for compounded preparations be determined?

Is intravenous ketamine useful for the treatment of major depressive disorder?

July 2014 FAQs

Can patients with recurrent C difficile infection be treated with a prepared fecal microbiota transplant product?

What data are available comparing liposomal bupivacaine to other agents?

What is the Target: Stroke initiative and its effect on stroke outcomes?

June 2014 FAQs

What are the recommendations regarding blood pressure management in patients with an acute ischemic stroke?

What evidence supports the efficacy of the new oral factor Xa inhibitor, edoxaban?

Does testosterone increase the risk of a cardiovascular event?

May 2014 FAQs

What is the effective dose and duration of oral ribavirin for immunocompromised adult patients with RSV infection?

Is there any information regarding reducing the adverse effects from acetylcysteine in acetaminophen overdose?

What are the current guidelines on treatment of hyponatremia with vasopressin antagonists?

April 2014 FAQs

Is there a benefit to using colloid solutions versus crystalloid solutions as fluid resuscitation for patients with hypovolemic shock?

What drug products may be used in patients with anemia or hemorrhage who are Jehovah’s Witnesses?

What data are available to direct the dosing weight used for daptomycin in obesity?

March 2014 FAQs

Are there benefits to using genotype-guided warfarin dosing for INR control?

Does perioperative use of selective serotonin reuptake inhibitors increase the risk of adverse outcomes?

What is the evidence for the use of albumin for treatment of intradialytic hypotension?

February 2014 FAQs

What are the key features of the new hypertension treatment guidelines?

How do the novel oral anticoagulants compare to low-molecular-weight heparin for prevention of venous thromboembolism in patients undergoing total hip or knee replacements?

Is there evidence to support the use of lidocaine to reduce pain associated with potassium infusions?

January 2014 FAQs

What is the latest evidence associating statin use with myopathy?

What are current best practices for prevention of central-line associated bloodstream infections?

What are the key features of the new cholesterol treatment guidelines?


FAQs 2013

FAQs 2012

FAQs 2011

FAQs 2010

FAQs 2009

FAQs 2008

FAQs 2007

FAQs 2006

FAQs 2003